Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024)

Orthofix Medical's Restructuring Costs history spans 2 years, with the latest figure at $1.3 million for Q4 2024.

  • For the quarter ending Q4 2024, Restructuring Costs rose 30.72% year-over-year to $1.3 million, compared with a TTM value of $9.4 million through Dec 2024, down 51.61%, and an annual FY2024 reading of $9.4 million, up 697.28% over the prior year.
  • Restructuring Costs for Q4 2024 was $1.3 million at Orthofix Medical, up from $505000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $18.2 million in Q1 2023, with the low at -$92000.0 in Q3 2023.